Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026 (Oliver Barnes/Financial Times)

Oliver Barnes / Financial Times:
Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026  —  Deal for software group marks one of the biggest private equity exits of the year  —  Life sciences group Thermo Fisher has sealed …

Posted from: this blog via Microsoft Power Automate.

Daily Deals